首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >County-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research
【24h】

County-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research

机译:县级成本效益阈值:初步估计和进一步研究的需要

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Cost-effectiveness analysis can guide policymakers in resource allocation decisions. It assesses whether the health gains offered by an intervention are large enough relative to any additional costs to warrant adoption. When there are constraints on the health care system's budget or ability to increase expenditures, additional costs imposed by interventions have an "opportunity cost" in terms of the health foregone because other interventions cannot be provided. Cost-effectiveness thresholds (CETs) are typically used to assess whether an intervention is worthwhile and should reflect health opportunity cost. Nevertheless, CETs used by some decision makers such as the World Health Organization that suggested CETs of 1 to 3 times the gross domestic product (GDP) per capita do not. Objectives: To estimate CETs based on opportunity cost for a wide range of countries. Methods: We estimated CETs based on recent empirical estimates of opportunity cost (from the English National Health Service), estimates of the relationship between country GDP per capita and the value of a statistical life, and a series of explicit assumptions. Results: CETs for Malawi (the country with the lowest income in the world), Cambodia (with borderline low/low-middle income), El Salvador (with borderline low-middle/upper-middle income), and Kazakhstan (with borderline high-middle/high income) were estimated to be $3 to $116 (1%-51% GDP per capita), $44 to $518 (4%51%), $422 to $1967 (11%-51%), and $4485 to $8018 (32%-59%), respectively. Conclusions: To date, opportunity-cost-based CETs for low-/middle-income countries have not been available. Although uncertainty exists in the underlying assumptions, these estimates can provide a useful input to inform resource allocation decisions and suggest that routinely used CETs have been too high.
机译:背景:成本效益分析可以指导决策者进行资源分配决策。它评估了干预措施所带来的健康收益相对于任何需要采用的额外费用是否足够大。当卫生保健系统的预算或增加支出的能力受到限制时,由于无法提供其他干预措施,干预措施带来的额外费用在医疗方面就被称为“机会成本”。成本效益阈值(CET)通常用于评估干预是否值得,并应反映健康机会成本。但是,某些决策者(例如世界卫生组织)使用的CET并不认为CET是人均国内生产总值(GDP)的1到3倍。目标:根据广泛国家的机会成本估算CET。方法:我们根据机会成本(来自英国国家卫生局)的最新经验估计,国家人均GDP与统计生命值之间的关系估计以及一系列明确假设来估计CET。结果:马拉维(世界上收入最低的国家),柬埔寨(中低收入/中低收入的临界点),萨尔瓦多(中低收入/中高收入的临界点)和哈萨克斯坦(高收入的临界值)的CET -中/高收入)估计为3到116美元(人均GDP的1%-51%),44到518美元(4%51%),422到1967美元(11%-51%)和4485到8018美元( 32%-59%)。结论:迄今为止,还没有针对中低收入国家的基于机会成本的CET。尽管基本假设中存在不确定性,但这些估计值可以提供有用的信息来指导资源分配决策,并表明常规使用的CET值过高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号